期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy
1
作者 Han Wu Yumei Wang +3 位作者 Zekai Ren Hailin Cong Youqing Shen Bing Yu 《Chinese Chemical Letters》 2025年第4期9-19,共11页
Glioma is the most common malignant tumor of the brain. The postoperative recurrence rate was high,and the 2-year survival rate only increased by 20%–25%. The reason is the blood-brain barrier(BBB). BBB is a physical... Glioma is the most common malignant tumor of the brain. The postoperative recurrence rate was high,and the 2-year survival rate only increased by 20%–25%. The reason is the blood-brain barrier(BBB). BBB is a physical barrier that stabilizes the physiological environment of brain tissue and protects the central nervous system from the invasion of harmful substances. Drug delivery based on nanotechnology and nanocarriers has attracted much attention due to its biological safety, continuous drug release time,increasing solubility, biological drug activity, and enhanced BBB permeability. By modifying different substances on the surface of nanocarriers, the BBB is bypassed by receptor-mediated and cell endocytosis and exocytosis. In addition, the purpose of bypassing BBB-targeted drug delivery can also be achieved by intranasal administration and local administration. This paper reviews different target transport mechanisms, mainly in invasive and non-invasive strategies, the nanocarriers that have made progress and the nanocarrier strategy of bypassing BBB are listed. 展开更多
关键词 GLIOMA Blood-brain barrier NANOCARRIERS Drug delivery adsorption-mediated transport Receptor-mediated transport
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部